Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release Jan 19 2023
Business
Jan 19 2023
3 min read

Press Release Jan 19 2023

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 19, 2023, titled "Alembic Pharmaceuticals receives USFDA Tentative Approval for Acalabrutinib Capsules, 100 mg".

View Attachment